Front Row Advisors’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14
Closed -$1.29K 825
2024
Q2
$1.29K Hold
14
﹤0.01% 879
2024
Q1
$1.59K Buy
+14
New +$1.4K ﹤0.01% 862
2023
Q4
Sell
-14
Closed -$1.28K 792
2023
Q3
$1.28K Hold
14
﹤0.01% 851
2023
Q2
$2K Hold
14
﹤0.01% 827
2023
Q1
$1K Hold
14
﹤0.01% 894
2022
Q4
$1K Hold
14
﹤0.01% 868
2022
Q3
$1K Hold
14
﹤0.01% 905
2022
Q2
$2K Hold
14
﹤0.01% 851
2022
Q1
$1K Hold
14
﹤0.01% 919
2021
Q4
$1K Hold
14
﹤0.01% 931
2021
Q3
$2K Hold
14
﹤0.01% 885
2021
Q2
$2K Hold
14
﹤0.01% 887
2021
Q1
$1K Hold
14
﹤0.01% 934
2020
Q4
$2K Hold
14
﹤0.01% 847
2020
Q3
$2K Hold
14
﹤0.01% 845
2020
Q2
$1K Hold
14
﹤0.01% 954
2020
Q1
$1K Hold
14
﹤0.01% 933
2019
Q4
$2K Hold
14
﹤0.01% 813
2019
Q3
$2K Hold
14
﹤0.01% 813
2019
Q2
$2K Hold
14
﹤0.01% 873
2019
Q1
$1K Hold
14
﹤0.01% 1001
2018
Q4
$1K Hold
14
﹤0.01% 982
2018
Q3
$1 Hold
14
﹤0.01% 942
2018
Q2
$1 Hold
14
﹤0.01% 973
2018
Q1
$1K Hold
14
﹤0.01% 909
2017
Q4
$1K Buy
+14
New +$955 ﹤0.01% 811

Other funds holding USPH

Front Row Advisors's USPH Position: Q3 2024 in Review

Front Row Advisors sold out of US Physical Therapy (USPH) in Q3 2024, closing a stake of 14 shares — an estimated $1.29K sold.

Front Row Advisors first reported a position in USPH in Q4 2017 and held it in 26 quarters. The position peaked at $2K in Q2 2023. 257 funds tracked by Wall St. Rank hold USPH as of Q3 2024.

  • Front Row Advisors reported no remaining US Physical Therapy position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 14 US Physical Therapy shares in Q3 2024, an estimated $1.29K.
  • Front Row Advisors first reported a position in US Physical Therapy in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's US Physical Therapy position peaked at $2K in Q2 2023.
  • 257 funds tracked by Wall St. Rank held US Physical Therapy as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.